DexCom (DXCM) Misses Q4 EPS by 1c, Offers FY Guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.92 -0.22%
EPS Growth %: +27.1%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +27.1%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.91, $0.01 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $568.9 million versus the consensus estimate of $554.7 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.21-2.31 billion.
- Non-GAAP Gross profit margin of approximately 65%
- Non-GAAP Operating margin of approximately 13%
- Adjusted EBITDA margin of approximately 23%
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
